论文部分内容阅读
生脉散,临床上用于治疗休克、急性心肌梗塞,冠心病,心肌炎及其后遗症等,获得良效。现漫谈如下: 一、方剂来源与衍变生脉散最早见于李东垣《内外伤变惑论》,由人参9克、麦冬15克、五味子6克组成。《医部全录》生脉散条下记载人参5钱、麦冬3钱、五味子2钱。近代文献记载如《药物与方剂》生脉散由吉林参2钱,麦冬4钱,五味子1.5钱组成。而《中国药典》85年版记载生脉饮由人参100克,麦冬200克,五味子100克。武汉地区所见处方有三种:一方党参、麦冬、五味子称生脉冲剂;二方红参15克,麦冬15克,五味子15克制成胶囊;三方西洋参
Shengmaisan is clinically used for the treatment of shock, acute myocardial infarction, coronary heart disease, myocarditis and its sequelae, and has good results. Now talk about the following: First, the origin and development of prescription Shengmai powder was first seen in Li Dongfu “Inner and outer injury”, by the ginseng 9 grams, Ophiopogon 15 grams, Schisandra 6 grams. “Whole Ministry of Medicine records” Shengmai scattered records under the ginseng 5 money, Ophiopogon 3 money, Schisandra 2 money. Modern literature records such as “drugs and prescriptions” were scattered from the Jilin Participation 2 money, Ophiopogon japonicus 4 money, Schisandra 1.5 money. The 85th edition of the “Chinese Pharmacopoeia” records that Shengmai Yin consists of 100 grams of ginseng, 200 grams of Ophiopogon, and 100 grams of Schisandra. There are three prescriptions seen in Wuhan: one side of the Codonopsis, Ophiopogon japonicus, Schisandra called pulse agent; two red ginseng 15 grams, Ophiopogon 15 grams, 15 grams of Schisandra made into capsules; tripartite American ginseng